> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Prader-Willi Syndrome NDA
- URL: https://www.fdaweb.com/panel-to-review-prader-willi-syndrome-nda/
- Published: 2021-09-01T12:00:00.000Z
- Updated: 2026-09-14T17:12:45.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150055

*Federal Register* notice: FDA has announced an 11/4 Psychopharmacologic Drugs Advisory Committee meeting. Panel members are scheduled to discuss a Levo Therapeutics NDA for carbetocin nasal spray, for the proposed treatment of hyperphagia, anxiety, and distress behaviors associated with Prader-Willi syndrome. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-09-01/pdf/2021-18892.pdf?ref=fdaweb.com).